UOC
IBB icon

UBS O'Connor’s iShares Biotechnology ETF IBB Stock Holding History

UBS O'Connor’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-40,000
Closed -$4.71M – 979
2022
Q2 		$4.71M Buy
+40,000
New +$4.75M 0.05% 341
2016
Q2 		– Sell
-59,010
Closed -$5.13M – 452
2016
Q1 		$5.13M Buy
+59,010
New +$5.28M 0.09% 204

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS O'Connor's IBB Position: Q3 2022 in Review

UBS O'Connor sold out of iShares Biotechnology ETF (IBB) in Q3 2022, closing a stake of 40,000 shares — an estimated $4.71M sold.

UBS O'Connor first reported a position in IBB in Q1 2016 and held it in 2 quarters. The position peaked at $5.13M in Q1 2016. 829 funds tracked by Wall St. Rank hold IBB as of Q3 2022.

  • UBS O'Connor reported no remaining iShares Biotechnology ETF position as of Q3 2022 after selling out during the quarter.
  • UBS O'Connor sold 40,000 iShares Biotechnology ETF shares in Q3 2022, an estimated $4.71M.
  • UBS O'Connor first reported a position in iShares Biotechnology ETF in Q1 2016 and held it in 2 quarters.
  • UBS O'Connor's iShares Biotechnology ETF position peaked at $5.13M in Q1 2016.
  • 829 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2022.

Based on UBS O'Connor's 13F filing for Q3 2022, filed 14 Nov 2022.